PKM and glioblastoma: Notably, disrupting the ALDH1A3-PKM2 interaction has been shown to potentiate chemoradiotherapy-induced apoptosis in GBM cells, offering a potential therapeutic strategy for ALDH1A3hi GBM (Li et al., 2024a).